Literature DB >> 20003464

A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation.

Ha Vinh1, Nguyen Thi Khanh Nhu, Tran Vu Thieu Nga, Pham Thanh Duy, James I Campbell, Nguyen Van Minh Hoang, Maciej F Boni, Phan Vu Tra My, Christopher Parry, Tran Thi Thu Nga, Pham Van Minh, Cao Thu Thuy, To Song Diep, Le Thi Phuong, Mai Thu Chinh, Ha Thi Loan, Nguyen Thi Hong Tham, Mai Ngoc Lanh, Bui Li Mong, Vo Thi Cuc Anh, Phan Van Be Bay, Nguyen Van Vinh Chau, Jeremy Farrar, Stephen Baker.   

Abstract

BACKGROUND: Shigellosis remains considerable public health problem in some developing countries. The nature of Shigellae suggests that they are highly adaptable when placed under selective pressure in a human population. This is demonstrated by variation and fluctuations in serotypes and antimicrobial resistance profile of organisms circulating in differing setting in endemic locations. Antimicrobial resistance in the genus Shigella is a constant threat, with reports of organisms in Asia being resistant to multiple antimicrobials and new generation therapies.
METHODS: Here we compare microbiological, clinical and epidemiological data from patients with shigellosis over three different periods in southern Vietnam spanning 14 years.
RESULTS: Our data demonstrates a shift in dominant infecting species (S. flexneri to S. sonnei) and resistance profile of the organisms circulating in southern Vietnam. We find that there was no significant variation in the syndromes associated with either S. sonnei or S. flexneri, yet the clinical features of the disease are more severe in later observations.
CONCLUSIONS: Our findings show a change in clinical presentation of shigellosis in this setting, as the disease may be now more pronounced, this is concurrent with a change in antimicrobial resistance profile. These data highlight the socio-economic development of southern Vietnam and should guide future vaccine development and deployment strategies. TRIAL REGISTRATION: Current Controlled Trials ISRCTN55945881.

Entities:  

Mesh:

Year:  2009        PMID: 20003464      PMCID: PMC2803792          DOI: 10.1186/1471-2334-9-204

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  27 in total

Review 1.  Invasion of epithelial cells by bacterial pathogens the paradigm of Shigella.

Authors:  K Niebuhr; P J Sansonetti
Journal:  Subcell Biochem       Date:  2000

2.  Rapid emergence of third generation cephalosporin resistant Shigella spp. in Southern Vietnam.

Authors:  Ha Vinh; Stephen Baker; James Campbell; Nguyen Van Minh Hoang; Ha Thi Loan; Mai Thu Chinh; Vo Thi Cuc Anh; To Song Diep; Le Thi Phuong; Constance Schultsz; Jeremy Farrar
Journal:  J Med Microbiol       Date:  2009-02       Impact factor: 2.472

3.  Shifting serotypes, plasmid profile analysis and antimicrobial resistance pattern of shigellae strains isolated from Kolkata, India during 1995-2000.

Authors:  S Dutta; K Rajendran; S Roy; A Chatterjee; P Dutta; G B Nair; S K Bhattacharya; S-I Yoshida
Journal:  Epidemiol Infect       Date:  2002-10       Impact factor: 2.451

4.  Antimicrobial resistance trends in Shigella serogroups isolated in Israel, 1990-1995.

Authors:  A Mates; D Eyny; S Philo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-02       Impact factor: 3.267

Review 5.  The pathogenesis of Shigella flexneri infection: lessons from in vitro and in vivo studies.

Authors:  D J Philpott; J D Edgeworth; P J Sansonetti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

6.  Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid.

Authors:  H Vinh; J Wain; M T Chinh; C T Tam; P T Trang; D Nga; P Echeverria; T S Diep; N J White; C M Parry
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 May-Jun       Impact factor: 2.184

7.  Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans.

Authors:  K L Kotloff; F R Noriega; T Samandari; M B Sztein; G A Losonsky; J P Nataro; W D Picking; E M Barry; M M Levine
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  "Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli.

Authors:  A T Maurelli; R E Fernández; C A Bloch; C K Rode; A Fasano
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

9.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Authors:  K L Kotloff; J P Winickoff; B Ivanoff; J D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; M M Levine
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

10.  Occurrence of shigellosis in the young and elderly in rural China: results of a 12-month population-based surveillance study.

Authors:  Xuan-Yi Wang; Lin Du; Lorenz Von Seidlein; Zhi-Yi Xu; Ying-Lin Zhang; Zhi-Yong Hao; Oak-Pil Han; Jing-Chen Ma; Hye-Jon Lee; Mohammad Ali; Chang-Quan Han; Zhan-Chun Xing; Ji-Chao Chen; John Clemens
Journal:  Am J Trop Med Hyg       Date:  2005-08       Impact factor: 2.345

View more
  66 in total

Review 1.  Salmonella, Shigella, and yersinia.

Authors:  John P Dekker; Karen M Frank
Journal:  Clin Lab Med       Date:  2015-04-02       Impact factor: 1.935

Review 2.  Progress and pitfalls in Shigella vaccine research.

Authors:  Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein; Alessio Fasano; Karen L Kotloff; Myron M Levine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-19       Impact factor: 46.802

Review 3.  The genomic signatures of Shigella evolution, adaptation and geographical spread.

Authors:  Hao Chung The; Duy Pham Thanh; Kathryn E Holt; Nicholas R Thomson; Stephen Baker
Journal:  Nat Rev Microbiol       Date:  2016-02-29       Impact factor: 60.633

Review 4.  Shigellosis update: advancing antibiotic resistance, investment empowered vaccine development, and green bananas.

Authors:  Margaret Kosek; Pablo Peñataro Yori; Maribel Paredes Olortegui
Journal:  Curr Opin Infect Dis       Date:  2010-10       Impact factor: 4.915

5.  Shigella: A Highly Virulent and Elusive Pathogen.

Authors:  Mussaret Bano Zaidi; Teresa Estrada-García
Journal:  Curr Trop Med Rep       Date:  2014-06-01

6.  Shigellosis in Subjects with Traveler's Diarrhea Versus Domestically Acquired Diarrhea: Implications for Antimicrobial Therapy and Human Immunodeficiency Virus Surveillance.

Authors:  Carlos Toro; Ana Arroyo; Ana Sarria; Nuria Iglesias; Ana Enríquez; Margarita Baquero; Concepción Ladrón de Guevara
Journal:  Am J Trop Med Hyg       Date:  2015-07-20       Impact factor: 2.345

7.  The sudden dominance of blaCTX-M harbouring plasmids in Shigella spp. Circulating in Southern Vietnam.

Authors:  Nhu Thi Khanh Nguyen; Vinh Ha; Nga Vu Thieu Tran; Richard Stabler; Duy Thanh Pham; Thi Minh Vien Le; H Rogier van Doorn; Ana Cerdeño-Tárraga; Nicholas Thomson; James Campbell; Van Minh Hoang Nguyen; Thi Thu Nga Tran; Minh Van Pham; Thuy Thu Cao; Brendan Wren; Jeremy Farrar; Stephen Baker
Journal:  PLoS Negl Trop Dis       Date:  2010-06-08

8.  Distribution of Enteroinvasive and Enterotoxigenic Escherichia coli Across Space and Time in Northwestern Ecuador.

Authors:  Darlene Bhavnani; Rosa de los Ángeles Bayas; Velma K Lopez; Lixin Zhang; Gabriel Trueba; Betsy Foxman; Carl Marrs; William Cevallos; Joseph N S Eisenberg
Journal:  Am J Trop Med Hyg       Date:  2015-12-07       Impact factor: 2.345

9.  Prevalence, resistance patterns, and characterization of integrons of Shigella flexneri isolated from Jiangsu Province in China, 2001-2011.

Authors:  Y Xu; L Zhuang; H Kang; P Ma; T Xu; S Pan; B Gu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-24       Impact factor: 3.267

10.  Tracking the establishment of local endemic populations of an emergent enteric pathogen.

Authors:  Kathryn E Holt; Tran Vu Thieu Nga; Duy Pham Thanh; Ha Vinh; Dong Wook Kim; My Phan Vu Tra; James I Campbell; Nguyen Van Minh Hoang; Nguyen Thanh Vinh; Pham Van Minh; Cao Thu Thuy; Tran Thi Thu Nga; Corinne Thompson; Tran Thi Ngoc Dung; Nguyen Thi Khanh Nhu; Phat Voong Vinh; Pham Thi Ngoc Tuyet; Hoang Le Phuc; Nguyen Thi Nam Lien; Bui Duc Phu; Nguyen Thi Thuy Ai; Nguyen Manh Tien; Nguyen Dong; Christopher M Parry; Tran Tinh Hien; Jeremy J Farrar; Julian Parkhill; Gordon Dougan; Nicholas R Thomson; Stephen Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.